echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > R & D daily, Wanfu biological new coronavirus antibody rapid detection reagent was approved for market

    R & D daily, Wanfu biological new coronavirus antibody rapid detection reagent was approved for market

    • Last Update: 2020-02-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The novel coronavirus pneumonia model was successfully established by SHR5126, and CT was successfully established Ten new coronavirus detection kits have been approved; nature found that new immune cells are helpful for tumor immunotherapy We focus on the latest development of pharmaceutical research and development, and provide timely and accurate information reference for R & D personnel () 22, novel coronavirus products were detected in 3 enterprises by 3 new coronavirus products, including 2 colloidal gold antibody detection reagents and 1 isothermal amplification chip nucleic acid detection reagents, the State Drug Administration said 23, the novel coronavirus antibody test kit developed by Guangzhou Wanfu biotech Limited by Share Ltd announced that it had obtained the registration certificate through the State Food and Drug Administration's emergency examination and approval, and became the first official test site for the new crown virus antibody approved by the state On February 21, according to the nmpa website, the application for listing of six generic Lanthanum Carbonate Chewable Tablets of Hunan Mingrui Pharmaceutical Co., Ltd has been approved According to the timeline of the evaluation of the drug in insight database, it is expected that the possibility of approval is very high Hunan Mingrui Pharmaceutical Co., Ltd is expected to become the first domestic enterprise to win the first imitation of lanthanum carbonate On April 24, Hengrui released a notice that shr5126 tablets were approved for clinical use and were intended to be used for the treatment of solid patients, with specific indications to be determined in clinical trials (acceptance No.: cxhl1900399, cxhl1900400) The novel coronavirus pneumonia diagnostic system is jointly launched by Tiantan hospital, General Hospital of PLA and BioMind It is the AI diagnostic system for the real industry and the new AI pneumonia The novel coronavirus pneumonia can be diagnosed further, and it can further differentiate the new crown pneumonia from other pneumonia (viral pneumonia, bacterial pneumonia, etc.) In a recently published study, Professor jannic Boehm's team focused on RCAN1, which is overexpressed in the brains of Down's fetuses The team's work provides insight into how genes affect the way diseases behave The novel coronavirus pneumonia was developed by Xu Bo and the national Supercomputer Center of Tianjin on the 17 th The research team introduced an artificial intelligence model which used CT image to assist in the diagnosis of new coronavirus pneumonia The total accuracy of novel coronavirus pneumonia and other viral pneumonia is 83%, and it is fast and efficient Dr Barbara van Loon and others from the University of science and technology of Norway have made new discoveries on the repair of genetic information, which are published in the recent journal Nature communications The molecular elements that read DNA and correct DNA errors work together The team from MSK found a group of immune cells called ILC These cells exist in many different tissues and appear to have mild antitumor effect in normal resting state Activation of ILC with drugs can mobilize T cells to reduce the volume of pancreatic cancer tumor A new study has found that a mysterious genetic material can inhibit the spread of skin cancer cells, but as they mature, the material is often lost The new study was recently published in cancer cell Circular RNA does not encode proteins, but is part of a complex regulatory system, but its function is still unclear Researchers from the Wellcome Sanger Institute in the UK, the University of Newcastle and the University of Ghent in Belgium announced Monday that they had successfully mapped the first thymus tissue life cycle, opening the door to new therapies for cancer and autoimmune diseases Dr Sean Coakley and Professor Massimo Hilliard of the Clem Jones Alzheimer's research center at the Queensland Brain Institute at the University of Queensland have found a way in which cells control the stickiness of molecular glue, which protects connections between brain cells, to prevent neurodegeneration A new paper in nutrition reviews found that quercetin intake significantly reduced hypertension in patients with cardiovascular disease The good effect of quercetin on blood pressure supports the use of quercetin in the treatment of hypertension Researchers from the University of Toronto found that it is the active process rather than the passive process that determines which nanoparticles enter the solid tumor This discovery overturned previous ideas in the field of cancer nano medicine and pointed out the direction for more effective nano therapy Science published a research paper from Harvard Medical School and cancer center of Massachusetts General Hospital Researchers found that the invasion and poor prognosis of breast cancer are closely related to the content of ribosomal protein On the basis of the existing targeted therapy, regulating the ribosome function of cancer cells can effectively reduce the spread of breast cancer in mouse models.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.